Sphera Funds Management Ltd. Aptinyx Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$1.99 - $4.4 $819,215 - $1.81 Million	-411,666 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$1.81 - $5.03 $745,115 - $2.07 Million	411,666 New	411,666 $889,000
Q3 2018 Nov 14, 2018	SELL	$20.21 - $31.85 $2.07 Million - $3.26 Million	-102,474 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$19.83 - $24.17 $2.03 Million - $2.48 Million	102,474 New	102,474 $2.48 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.